This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Advance Auto Parts, Inc., (NYSE: AAP), a leading automotive aftermarket retailer of parts, batteries, accessories, and maintenance items, is proud to announce the launch of its 2012 sneaker sales campaign. This year marks Advance’s 19
th consecutive year of support for JDRF in their efforts toward curing, treating, and preventing type 1 diabetes. In the past 18 years, Advance has raised more than $31 million for JDRF, including a record-breaking campaign that raised $5 million for diabetes research in 2011 making Advance JDRF’s number one corporate partner in 2011. Advance and its Team Members are tireless in their efforts to give back to the communities in which they live and work.
“Our annual JDRF Sneaker Campaign is an inspiring time of year for our Company because it clearly shows our Team’s commitment to serving our community. The $31 million-plus that we have raised over the years is proof that Service is our best part - not only for our Commercial and DIY customers, but for our communities as well,” said Darren Jackson, President and Chief Executive Officer. “This year, our team is asking every customer to buy a pair of sneakers to double their support for curing juvenile diabetes and be a superhero's hero. Our team is striving to save the day for people suffering from type 1 diabetes.”
The Company’s sneaker sales program, which will be held at more than 3,600 stores in 39 states, Puerto Rico and the Virgin Islands, begins tomorrow, August 23 and runs through October 6. Customers can save the day and purchase paper sneakers that benefit the charity including $1, $5, $25 or $50 sneakers. The Advance team then displays the customer purchased paper sneakers in the store windows to show support for this worthwhile cause. Proceeds from every sneaker sold go directly to JDRF and help bring the organization one step closer to finding a cure.